Perrigo Co PLC (PRGO)
52.29
+0.48 +0.93%
NYSE
Dec 6, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.710B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.80 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 246.50M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 34.66% |
| Profit Margin (Quarterly) | 7.74% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 1.57% |
| Price and Valuation | |
| Market Cap | 7.117B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 1.515 |
| PE Ratio (TTM) | 29.05 |
| Price to Book Value | 1.236 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.5801 |
| Free Cash Flow (Quarterly) | 104.40M |
| Return on Equity (TTM) | Upgrade |
View All PRGO News
News
-
WireHeadlineTime (ET)
-
Yahoo12/06 11:31
-
Yahoo12/05 06:26
-
Yahoo12/04 09:11
-
PR Newswire12/02 16:30
-
SA Breaking News11/21 17:03
-
SA Breaking News11/20 07:54
-
Yahoo11/15 12:29
-
PR Newswire11/13 09:29
-
Yahoo11/07 13:09
-
Yahoo11/06 16:14
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 02/27/2020 16:30 EST | Misc | Perrigo Co PLC Fourth Quarter Earnings Conference Call in 2019 |
| 02/27/2020 | Earnings | Perrigo Co PLC Fourth Quarter Earnings in 2019 Release |
| 11/27/2019 | Dividends | Amount: 0.21, Declared Date: Nov 04 2019, Pay Date: Dec 17 2019 |
| 11/06/2019 | Earnings | Perrigo Co PLC Third Quarter Earnings for 2019 Release |
| 11/06/2019 08:00 EST | Misc | Perrigo Co PLC Third Quarter Earnings Conference Call for 2019 |
| 08/29/2019 | Dividends | Amount: 0.21, Declared Date: Jul 31 2019, Pay Date: Sep 17 2019 |
| 08/08/2019 08:00 EDT | Misc | Perrigo Co PLC Second Quarter Earnings Conference Call in 2019 |
| 08/08/2019 | Earnings | Perrigo Co PLC Second Quarter Earnings in 2019 Release |
| 05/30/2019 | Dividends | Amount: 0.21, Declared Date: Apr 26 2019, Pay Date: Jun 18 2019 |
| 05/09/2019 08:00 EDT | Misc | Perrigo Co PLC First Quarter Earnings Conference Call in 2019 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.perrigo.com
- Investor Relations URL: http://perrigo.investorroom.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Equity Style: Mid Cap/Value
- Next Earnings Release: Feb. 27, 2020
- Last Earnings Release: Nov. 06, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Nov. 27, 2019
- Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 52.29 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| PFPWX | Parnassus Endeavor Institutional | 4.42% |
| XPH | SPDR® S&P Pharmaceuticals ETF | 3.82% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 2.78% |
| PBE | Invesco Dynamic Biotech & Genome ETF | 2.78% |
| IHE | iShares US Pharmaceuticals ETF | 2.77% |
| TMCJX | Touchstone Mid Cap C | 2.49% |
| EAFRX | First Eagle Fund of America R4 | 2.48% |
| RRMVX | T. Rowe Price Mid-Cap Value R | 2.13% |
| PPH | VanEck Vectors Pharmaceutical ETF | 1.74% |
| FMQSX | Franklin Mutual Quest R | 1.71% |
| DFTVX | DFA US Targeted Value R1 | 0.47% |
| SIZE | iShares Edge MSCI USA Size Factor ETF | 0.18% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PRGO Tweets Stocktwits
Advertisement
